Page précédente
Abstracts Strasbourg 2004
| Type présentation | Jour(s) | N° Session | N° | Auteurs | Titre | Adresses |
|---|---|---|---|---|---|---|
| Orale | Lundi 26 | 3 | O11 | JS Hulot (1); JM Treluyer (2); C Chiron (3); S Tonnelier (2); P Lechat (1); G Pons (2); | Triangular test (TT), a sequential approach for comparative trials in children Abstract complet |
(1) Pharmacologie, Hôpital Pitié-Salpêtrière, Paris; (2) Pharmacologie, Hôpital Cochin – Saint Vincent de Paul, Paris; (3) Neuropediatrie, Hôpital Cochin – Saint Vincent de Paul, Paris; |
| Orale | Lundi 26 | 3 | O12 | I Berlin (1); J Medioni (2); A Mallet (2); | Increased risk of relapse rate after stopping nicotine replacement therapies. A mathematical modeling approach Abstract complet |
(1) Sce de Pharmacologie, GHU Pitié-Salpêtrière, Paris; (2) Sce de Biostatistique, Faculté de Médecine Pitié-Salpêtrière, Paris; |
| Orale | Lundi 26 | 3 | O13 | N Picard (1); Y Le Meur (2); JC Szelag (2); P Marquet (1); | Glucuronidation of mycophenolic acid (MPA): identification of the UDP-glucuronosyltransferase (UGT) isoforms producing MPA-phenyl-glucuronide and MPA-acyl-glucuronide Abstract complet |
(1) Service de Pharmacologie et Toxicologie, CHU de Limoges, Limoges; (2) Service de Néphrologie-Hémodialyse, CHU de Limoges, Limoges; |
| Orale | Lundi 26 | 3 | O14 | M Billing-Grima (1); C Coquard (1); J Steger (1); M Barthelmebs (1); JL Imbs (2); | Dual renin-angiotensin system blockade effects on plasma and renal angiotensin II levels Abstract complet |
(1) Institut de Pharmacologie, Faculté de Médecine, Strasbourg; (2) Service d’Hypertension, Maladies Vasculaires et Pharmacologie Clinique, Hôpitaux Universitaires, Strasbourg; |
| Orale | Lundi 26 | 3 | O15 | F Saint-Marcoux (1); C Knoop (2); J Debord (1); P Thiry (3); A Rousseau (1); M Estenne (2); P Marquet (1); | Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplants and design of Bayesian estimators using limited sampling strategies Abstract complet |
(1) Department of Pharmacology-Toxicology, University Hospital, Limoges; (2) Department Chest Medicine, Erasme University Hospital, Bruxelles, Belgique; (3) Department of Clinical Chemistry, Erasme University Hospital, Bruxelles, Belgique; |
| Orale | Lundi 26 | 3 | O16 | M Benouchan (1); F Do Nascimento (1); GY Perret (2); BM Colombo (1); | Gene delivery of Escherichia coli nitroreductase into endothelial cells prolongs the survival of tumor-bearing mice treated with the prodrug CB1954 Abstract complet |
(1) UPRES 2360, Université Paris-XIII, Faculté de Médecine, Bobigny; (2) ERIT-M 0204, Laboratoire de Pharmacologie, Université Paris-XIII, Faculté de Médecine, Bobigny; |
Page précédente